期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

恶性高热 被引量：3

Malignant Hyperthermia (review)
下载PDF
导出
摘要 恶性高热是一种少见的常染色体显性遗传疾病。本文对恶性高热的发病率、发病机制及诊断等几个方面的进展给予综述。 Malignant hyperthermia is a rare autosomal dominant genetic disorder. This article would review the advance in the researchs of malignant hyperthermia, including its incidence, pathogenesis and diagnosis.
作者 苏慧 马维娅 吴士文
机构地区 武警总医院神经内科
出处 《中国康复理论与实践》 CSCD 2009年第1期2-4,共3页 Chinese Journal of Rehabilitation Theory and Practice
基金 武警课题资助项目(WZ200506)
关键词 恶性高热 遗传病 发病机制 诊断 综述 malignant hyperthermia genetic disorder pathogenesis diagnosis review
分类号 R746.9 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献38

  • 1Denborough M, Lovell R. Anaesthetic deaths in a family[J]. Lancet, 1960,2:45.
  • 2Rosenberg H, Davis M, James D, et al. Malignant hyperthermia [J]. Orphanet J Rare Diseases, 2007,2:21.
  • 3Chamley D,Polloek AN, Brown RL. Malignant hyperthermia in in fancy and identification of a novel RYR1 mutation[J]. Br J Anesth, 2000,84:500-504.
  • 4Pollock N, Langtont E, Stoweli K, et al.Safe duration of postopera rive monitoring for malignant hyperthermia susceptible patients[J]. Anaesth Intensive Care, 2004,32(4):502-509.
  • 5Halsall PJ, Philip M. Malignant hyperthermia[J]. Br J Anaesth, 2003,12(3) =5-9.
  • 6Monnier N,Krivosic-Horber R,Payen JF,et al. Presence of two different genetic traits in malignant hyperthermia families: Implication for genetic analysis, diagnosis, and incidence of malignant hyper thermia susceptibility[J]. Anesthesiology, 2002.97.1067-1074
  • 7Ibarra CA, Wu S, Murayama K, et al. Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing[J]. Anesthesiology, 2006, 104:1146-1154.
  • 8Tokunaga C, Hiramatsu Y, Noma M, et al. Delayed onset malignant hyperthermia after a closure of ventricular septaldefect[J]. Kyobu Geka, 2005,58(3) :201-205.
  • 9Heggie JE. Malignant hyperthermia: considerations for the general surgeon[J].Can J Surg,2002,45:369-372.
  • 10Vorrakitpokatorn P, Limsakul A. Drug-induced hyperthermia and rhabdomyolysis during the perioperative period: report of three patients[J]. J Med Assoc Thai, 2002,85: S884-S892.

二级参考文献30

  • 1葛亮,张进,肖波,李静,张宁,胡珏.中央轴空病3例报告[J].临床神经病学杂志,2004,17(3):209-209. 被引量：4
  • 2Quinlivan RM,Muller CR,Davis M,et al.Central core disease:clinical,pathological,and genetic features.Arch Dis Child,2003,88:1051-1055.
  • 3Wu S,Carlos AIM,Christine M,et al.Central core disease is due to RyR1 mutations in more than 90% of patients.Brain,2006[Epub ahead of print].
  • 4Romero NB,Monnier N,Viollet L,et al.Dominant and recessive central core disease associated with RYR1 mutations and fetal akinesia.Brain,2003,126 (Pt 11):2341-2349.
  • 5De Cauwer H,Heytens L,Martin JJ.Workshop report of the 89th ENMC International Workshop:Central Core Disease,19th-20th January 2001,Hilversum,The Netherlands.Neuromuscul Disord,2002,12:588-595.
  • 6Ferreiro A,Monnier N,Romero NB,et al.A recessive form of central core disease,transiently presenting as multi-minicore disease,is associated with a homozygous mutation in the ryanodine receptor type 1 gene.Ann Neurol,2002,51:750-759.
  • 7Sewry CA,Muller C,Davis M,et al.The spectrum of pathology in central core disease.Neuromuscul Disord,2002,12:930-938.
  • 8Scacheri PC,Hoffman EP,Fratkin JD,et al.A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy.Neurology,2000,55:1689-1696.
  • 9Gommans IM,Davis M,Saar K,et al.A locus on chromosome 15q for a dominantly inherited nemaline myopathy with core-like lesions.Brain,2003,126(Pt 7):1545-1551.
  • 10North K.Myology.3rd edition.In:Engel AG,Franzini-Armstrong C,editors.New York:McGraw-Hill,2004.1475-1480.

共引文献7

同被引文献30

  • 1王颖林,郭向阳,罗爱伦.我国大陆恶性高热病例的分析[J].中华麻醉学杂志,2006,26(2):107-109. 被引量：45
  • 2Ronald D,Miller.米勒麻醉学[M].北京:北京大学医学出版社,2006.
  • 3Halsall PJ, Philip M. Malignant hyperthermia [ J ]. Br J Anaesth, 2003,12(3) :5 -9.
  • 4McGarthy EJ. Malignant hyperthermia: pathophysiology, clinical presentation, and treatment. AACN Clin Issues, 2004, 15 (2) : 231 - 237.
  • 5Hopkins PM. Malignant hyperthermia: advances in clinicalman- agement and diagnosis. Br J Anaesth ,2000,85 ( 1 ) : 118 - 128.
  • 6赵建生 王准胜.氯胺酮可疑诱发小儿恶性高热一例[J].中华麻醉学杂志,2001,21(2):79-79.
  • 7Kozack JK, Macltyre DL. Maligant hyperthermia. Phys Ther, 2001,81 (3) :945 -951.
  • 8Robinson R, Hopkins P, Carsana A, et al. Several interacting genes influence the malignant hyperthermia phenotype. Hum Genet,2003,112(2) :217 -218.
  • 9Levitt RC, Olckers A, Meyers S, et al. Evidence for the localiza- tion of amalignant hyperthermia susceptibility locus ( MHS 2) to human chromosome 17q. Genomics, 1992,14 (3) :562 - 566.
  • 10Ording H. Pathophysiology of malignant hyperthermia. Ann Fr Anesth Reanim, 1989,8(5) : 411 -416.

引证文献3

中国康复理论与实践
2009年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部